Creation, Implementation and Validation of Intra- and Postoperative Risk Prediction Models

NCT ID: NCT06411496

Last Updated: 2024-05-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

112745 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-01

Study Completion Date

2023-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project aims to create and validate surgical risk prediction models for the prediction of complications in patients pending surgery during the operation, in the immediate postoperative period and up to one month after discharge.

At present there is no risk assessment system in place, except for the ASA scale which is mainly based on the subjective impression of the facultative, who assesses it in the universal preoperative consultations that we have planned in the system. In this project we intend to provide robust models, based on the analysis of data from patients in 4/5 Basque hospitals, i.e. generated in our population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A three-phase study has been designed:

1. st phase: Derivation and internal validation of the predictive model by means of a reprospective cohort study in which patients operated on at the Galdakao-Usansolo Hospital (HGU), Urduliz Hospital (HU), Basurto University Hospital (HUB), Donostia University Hospital (HUD) and Araba University Hospital (HUA) will be recruited. Hospital universitario de Donostia (HUD) and Hospital universitario de Araba (HUA) over XXX years and data will be obtained from the preoperative period until the month of discharge from the operation. For the identification and creation of these models, machine learning techniques will be used with the main purpose of identifying variables not described in the literature. Machine learning is the most important branch of Artificial Intelligence. Within Machine Learning, supervised learning is the most widely used area. Supervised learning allows computers to learn to perform tasks by discovering and exploiting complex patterns in large amounts of data. In the specific case of data from electronic medical records, Machine Learning algorithms allow us to use the historical data of each patient so that the computer learns to anticipate future events in a personalised way.
2. nd phase: External validation of the models created in the first phase in a cohort of patients operated on in 2020 in the same centres. The methodology proposed by Debray et al. will be applied.
3. rd phase: Evaluation of results after the implementation of the models in the EHR of the Galdakao-Usansolo Hospital in the form of an 'Action Guide'. Based on the risk stratification carried out in the previous phases, the anaesthesia department will create recommendations for action according to the level of risk. The percentages of mortality and intra- and postoperative complications will be compared by means of a quasi-experimental intervention study, comparing the results of the HGU hospital where the risk scale and the consequent recommendations will be implemented, before and after its implementation, and also comparing them with the percentages of patients who become complicated and/or die in HU, HUB, HUD and HUA, where the usual clinical practice will be followed, based on the ASA scale. This prospective cohort, once the risk scale has been implemented, will also be used for external validation (2020-2021).

Socio-demographic and clinical variables (main diagnosis, comorbidities, treatments, previous interventions, intraoperative data, post-operative data, procedures performed during hospitalisation, and complications up to one month after hospital discharge) and laboratory parameters will be collected.

This information will be extracted from osabide\'s global data exploitation system, Oracle Business Intelligence, and the laboratory data will be extracted from the information systems of the clinical laboratories of the centres involved.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Complications Risk Factors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Scheduled or urgent surgery

This is a retrospective cohort study recruiting surgical patients at Galdakao-Usansolo Hospital between 2019 and 2022. We used anonymized patient level data from patients in waiting list to be intervened in four public hospitals in Basque Country.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients over 18 years of age pending scheduled or urgent surgery in non-cardiac surgery.

Exclusion Criteria

* Surgery performed under local anaesthesia
* Paediatric Surgery
* Obstetric Patient
* Cardiac Surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Galdakao-Usansolo

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Susana García Gutiérrez

Colaborator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Francisco Mendoza, MD

Role: PRINCIPAL_INVESTIGATOR

Galdakao-Usansolo Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Galdakao Usansolo

Galdakao, Bizkaia, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PI2023/029

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.